Table II.
A, CD147 expression | |||||
---|---|---|---|---|---|
| |||||
Tumor type | Cases | Weak | Moderate | Strong | Positive rate (%) |
PMM | 128 | 28 | 68 | 32 | 78.1 |
MMM | 64 | 4 | 11 | 49 | 93.8a |
B, IGFBP2 expression | |||||
---|---|---|---|---|---|
| |||||
Tumor type | Cases | Weak | Moderate | Strong | Positive rate (%) |
PMM | 128 | 25 | 75 | 28 | 80.5 |
MMM | 64 | 6 | 18 | 40 | 90.6a |
P<0.05 vs. PMM. CD, cluster of differentiation; IGFBP2, insulin-like growth factor-binding protein 2; PMM, primary malignant melanoma; MMM, metastatic malignant melanoma.